CBSC (Cardiac Biotech Solutions) Short-Term Debt: $0.36 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cardiac Biotech Solutions Short-Term Debt?

Cardiac Biotech Solutions CBSC Short-Term Debt is $0.36 Mil as of Jun. 2025.

Cardiac Biotech Solutions's Short-Term Debt for the quarter that ended in Jun. 2025 was $0.36 Mil.

Cardiac Biotech Solutions's quarterly Short-Term Debt increased from Sep. 2024 ($0.14 Mil) to Mar. 2025 ($0.26 Mil) and increased from Mar. 2025 ($0.26 Mil) to Jun. 2025 ($0.36 Mil).

Cardiac Biotech Solutions's annual Short-Term Debt declined from Mar. 2023 ($0.10 Mil) to Mar. 2024 ($0.02 Mil) but then increased from Mar. 2024 ($0.02 Mil) to Mar. 2025 ($0.26 Mil).

Cardiac Biotech Solutions Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Cardiac Biotech Solutions Short-Term Debt Related Terms

Cardiac Biotech Solutions Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Cardiac Biotech Solutions's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiac Biotech Solutions Short-Term Debt Chart

Cardiac Biotech Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Short-Term Debt
0.38 0.04 0.10 0.02 0.26

Cardiac Biotech Solutions Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.14 0.26 0.36
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.36 Mil mean?
Cardiac Biotech Solutions (CBSC) has a Short-Term Debt of $0.36 Mil as of Jun. 2025.
Is Cardiac Biotech Solutions' Short-Term Debt too high?
Cardiac Biotech Solutions' current Short-Term Debt is $0.36 Mil.
How does Cardiac Biotech Solutions' Short-Term Debt compare to LUCY and NXGL?
Cardiac Biotech Solutions' Short-Term Debt of $0.36 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Cardiac Biotech Solutions's current Short-Term Debt is $0.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiac Biotech Solutions stock overvalued right now?
Cardiac Biotech Solutions (CBSC) has a current Short-Term Debt of $0.36 Mil. The current Short-Term Debt is $0.36 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Cardiac Biotech Solutions (CBSC), the current Short-Term Debt is $0.36 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cardiac Biotech Solutions Business Description

Address 10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135
Cardiac Biotech Solutions Inc, through its U.S. and international subsidiaries, provides products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.